CCEL logo

CRYO-CELL INTL INC

CCELNYSE AMERICAN
πŸ† #3826 by market capEarnings Oct 9US Equity
$3.51β–² $0.00 (+0.00%)
Market closed Β· at close
1hβ€”
24hβ–² 0.0%
7dβ–Ό 2.2%
14dβ–² 8.5%
30dβ–² 1.7%
1yβ–Ό 28.5%
🏦Market Cap
$28M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-1.3%
Declining
πŸ“ŠGross Margin
77.3%
High
πŸ’΅FCF Margin
19.6%
Healthy
βš–οΈP/S Ratio
0.9x
Cheap
Otter Score
66
Fair

Trading Snapshot

Day Range
$3.50 – $3.57
52-Week Range
$2.72 – $5.01
Volume
$2.40B
Avg Volume
$3.12B
Shares Outstanding
8.1M
Next Earnings
Oct 23, 2026

Fundamentals Snapshot

Annual Revenue
$32M
Last Q Revenue
$8M
P/E Ratio
-11.9
P/S Ratio
0.9x
EPS (TTM)
$-0.31
Dividend Yield
0.00%

Why Investors Own CCEL

  • βœ“High-growth profile β€” revenue up +35.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 72% gross margin and 10% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$32Mβ–² +32.6% YoY
Gross Margin (TTM)
71.9%β–² +1.4% YoY
Operating Income (TTM)
$11Mβ–² +32.6% YoY
Free Cash Flow (TTM)
$3Mβ–² +32.6% YoY

About CRYO-CELL INTL INC

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
66/100

Analyst Price Target

β“˜
Average Target
$3.39
β–Ό βˆ’3.3% Downside
High Target$3.92
Low Target$2.57
Based on 20 analysts

Latest News & Updates